GLUCOCEREBROSIDASE MUTATIONS IN GAUCHER DISEASE

被引:66
|
作者
BEUTLER, E
DEMINA, A
GELBART, T
机构
[1] Scripps Research Institute, La Jolla, 92037, California
关键词
D O I
10.1007/bf03403534
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: Thirty-six mutations that cause Gaucher disease, the most common glycolipid storage disorder, are known. Although both alleles of most patients with the disease contain one of these mutations, in a few patients one or both disease-producing alleles have remained unidentified. Identification of mutations in these patients is useful for genetic counseling. Materials and Methods: The DNA from 23 Gaucher disease patients in whom at least one glucocerebrosidase allele did not contain any of the 36 previously described mutations has been examined by single strand conformation polymorphism (SSCP) analysis, followed by sequencing of regions in which abnormalities were detected. Results: Eight previously undescribed mutations were detected. In exon 3, a deletion of a cytosine at cDNA nt 203 was found. In exon 6, three missense mutations were identified: a C --> A transversion at cDNA nt 644 (Ala(176) --> Asp), a C --> A transversion at cDNA nt 661 that resulted in a (Pro(182) --> Thr) and a G --> A transition at cDNA nt 721 (Gly(202) --> Arg). Two missense mutations were found in exon 7: a G --> A transition at cDNA nt 887 (Arg(257) --> Gln) and a C --> T at cDNA nt 970 (Arg(285) --> Cys). Two missense mutations were found in exon 9: a T --> G at cDNA nt 1249 (Trp(378) --> Gly) and a G --> A at cDNA nt 1255 (Asp(380) --> Asn). In addition to these disease-producing mutations, a silent C --> G transversion at cDNA nt 1431, occurring in a gene that already contained the 1226G mutation, was found in one family. Conclusions: The mutations described here and previously known can be classified as mild, severe, or lethal, on the basis of their effect on enzyme production and on clinical phenotype, and as polymorphic or sporadic, on the basis of the haplotype in which they are found. Rare mutations such as the new ones described here are sporadic in nature.
引用
收藏
页码:82 / 92
页数:11
相关论文
共 50 条
  • [21] Molecular analysis of Turkish Gaucher disease patients:: Identification of novel mutations in glucocerebrosidase (GBA) gene
    Emre, Serap
    Gurakan, Figen
    Yuce, Aysel
    Rolf, Arnold
    Scott, Ronald
    Ozen, Hasan
    EUROPEAN JOURNAL OF MEDICAL GENETICS, 2008, 51 (04) : 315 - 321
  • [22] Do mutations in the glucocerebrosidase gene modify the course of Parkinson disease? Family studies in patients with Gaucher disease.
    Goker-Alpan, O
    Schiffmann, R
    Lwin, A
    Sidransky, E
    AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 73 (05) : 449 - 449
  • [23] Glucocerebrosidase Mutations in Parkinson Disease
    O'Regan, Grace
    deSouza, Ruth-Mary
    Balestrino, Roberta
    Schapira, Anthony H.
    JOURNAL OF PARKINSONS DISEASE, 2017, 7 (03) : 411 - 422
  • [24] Glucocerebrosidase mutations and Parkinson disease
    Vieira, Sophia R. L.
    Schapira, Anthony H. V.
    JOURNAL OF NEURAL TRANSMISSION, 2022, 129 (09) : 1105 - 1117
  • [25] Glucocerebrosidase mutations and Parkinson disease
    Sophia R. L. Vieira
    Anthony H. V. Schapira
    Journal of Neural Transmission, 2022, 129 : 1105 - 1117
  • [26] Glucocerebrosidase isoforms in brains of patients with Gaucher disease.
    Walker, JM
    Orvisky, E
    Martin, BM
    Sidransky, E
    MOLECULAR GENETICS AND METABOLISM, 2004, 81 (03) : 163 - 163
  • [27] Convection perfusion of glucocerebrosidase for neuronopathic Gaucher's disease
    Lonser, RR
    Walbridge, S
    Murray, GJ
    Aizenberg, MR
    Vortmeyer, AO
    Aerts, JMFG
    Brady, RO
    Oldfield, EH
    ANNALS OF NEUROLOGY, 2005, 57 (04) : 542 - 548
  • [28] ELECTROPHORESIS OF GLUCOCEREBROSIDASE FROM NORMAL AND GAUCHER DISEASE FIBROBLASTS
    DALE, GL
    GUDAS, J
    WOLOSZYN, W
    BEUTLER, E
    AMERICAN JOURNAL OF HUMAN GENETICS, 1979, 31 (04) : 518 - 521
  • [29] Glucocerebrosidase inhibitors: future drugs for the treatment of Gaucher disease?
    Trapero, Ana
    Llebaria, Amadeu
    FUTURE MEDICINAL CHEMISTRY, 2014, 6 (09) : 975 - 978
  • [30] MOLECULAR-BIOLOGY OF GLUCOCEREBROSIDASE AND THE TREATMENT OF GAUCHER DISEASE
    BARRANGER, JA
    TOMICH, J
    WEILER, S
    SAKALLAH, S
    SANSIERI, C
    MIFFLIN, T
    BAHNSON, A
    WEI, FS
    WEI, JF
    VALLOR, M
    NIMGAONKAR, M
    BALL, E
    MOHNEY, T
    DUNIGAN, J
    OHASHI, T
    BANSAL, V
    MANNIONHENDERSON, J
    LIU, CM
    RICE, E
    CYTOKINES AND MOLECULAR THERAPY, 1995, 1 (03): : 149 - 163